TuHURA Biosciences, Inc. (HURA) CEO discloses 3.4M option grant terms in filing

Rhea-AI Filing Summary

TuHURA Biosciences, Inc. insider James Bianco, the company’s chief executive officer and a director, reported acquiring stock options on 12/12/2025. The options give him the right to buy up to 3,414,891 shares of TuHURA common stock at an exercise price of $1.02 per share and are scheduled to expire on 12/12/2035.

According to the filing, these options were acquired in a single transaction coded "A" and had a reported price of $0 for the derivative security itself. A footnote explains that one-third of the options become exercisable on each of the first, second, and third anniversaries of December 12, 2025. Following this transaction, Bianco beneficially owns 3,414,891 stock options directly.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bianco James A.

(Last) (First) (Middle)

10500 UNIVERSITY CENTER DRIVE, SUITE 110

(Street)

TAMPA FL 33612

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
TuHURA Biosciences, Inc./NV [ HURA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
12/12/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Options (Right to Buy)	$1.02	12/12/2025		A		3,414,891		(1)	12/12/2035	Common Stock	3,414,891	$0	3,414,891	D

Explanation of Responses:

1. One-third of the stock options become exercisable on the first, second, and third anniversary of December 12, 2025.

	/s/ Dan Dearborn as Power of Attorney for James Bianco	12/17/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did TuHURA Biosciences (HURA) report in this filing?

The filing states that James Bianco, TuHURA Biosciences’ chief executive officer and director, acquired 3,414,891 stock options on 12/12/2025 in a transaction coded "A" (acquisition).

What are the key terms of James Bianco’s TuHURA stock options?

Each option is an option (right to buy) TuHURA common stock at an exercise price of $1.02 per share, with an expiration date of 12/12/2035, and a reported derivative security price of $0.

How many TuHURA Biosciences shares underlie the new options reported by James Bianco?

The derivative securities are options linked to 3,414,891 shares of TuHURA Biosciences common stock, as shown in the underlying security column.

What is the vesting schedule for James Bianco’s TuHURA stock options?

A footnote explains that one-third of the stock options become exercisable on each of the first, second, and third anniversaries of December 12, 2025.

When do James Bianco’s TuHURA options expire, and how many does he own after this transaction?

The options are scheduled to expire on 12/12/2035. After this transaction, the filing reports that Bianco beneficially owns 3,414,891 derivative securities (stock options) directly.

How is ownership of the TuHURA options reported for James Bianco?

The ownership form for these 3,414,891 stock options is listed as Direct (D) in the filing.